(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors...
Stats | |
---|---|
Dagens volum | 321 167 |
Gjennomsnittsvolum | 707 477 |
Markedsverdi | 359.41M |
EPS | $0 ( 2024-03-13 ) |
Neste inntjeningsdato | ( $-0.560 ) 2024-06-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.480 |
ATR14 | $0.00900 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-03 | Redmile Group, Llc | Sell | 59 986 | Cash-settled Swaps |
2024-02-01 | Redmile Group, Llc | Sell | 19 700 | Cash-settled Swaps |
2024-02-01 | Redmile Group, Llc | Buy | 205 483 | Cash-settled Swaps |
2024-01-31 | Redmile Group, Llc | Buy | 150 000 | Cash-settled Swaps |
2024-01-29 | Redmile Group, Llc | Buy | 150 000 | Cash-settled Swaps |
INSIDER POWER |
---|
-45.66 |
Last 79 transactions |
Buy: 1 817 492 | Sell: 5 217 316 |
Volum Korrelasjon
ADC Therapeutics SA Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
K | 0.945 |
NKX | 0.942 |
OGN | 0.941 |
JWN | 0.941 |
SPCE | 0.937 |
ZME | 0.936 |
BIG | 0.933 |
BBWI | 0.933 |
GSL | 0.933 |
USPH | 0.931 |
10 Mest negative korrelasjoner | |
---|---|
FLRT | -0.949 |
SLB | -0.944 |
CANE | -0.944 |
OII | -0.943 |
IEZ | -0.94 |
OIH | -0.937 |
WHD | -0.937 |
HAL | -0.935 |
AFT | -0.934 |
BKR | -0.933 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
ADC Therapeutics SA Korrelasjon - Valuta/Råvare
ADC Therapeutics SA Økonomi
Annual | 2023 |
Omsetning: | $69.56M |
Bruttogevinst: | $67.03M (96.36 %) |
EPS: | $-2.94 |
FY | 2023 |
Omsetning: | $69.56M |
Bruttogevinst: | $67.03M (96.36 %) |
EPS: | $-2.94 |
FY | 2022 |
Omsetning: | $209.91M |
Bruttogevinst: | $205.33M (97.82 %) |
EPS: | $-1.990 |
FY | 2021 |
Omsetning: | $33.92M |
Bruttogevinst: | $32.52M (95.89 %) |
EPS: | $-3.52 |
Financial Reports:
No articles found.
ADC Therapeutics SA
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second-line transplant-ineligible patients; and Phase I clinical trial for treatment of relapsed or refractory non-hodgkin lymphoma (NHL). The company is also developing camidanlumab tesirine, an ADC that has completed Phase I clinical trial to treat relapsed or refractory NHL; in Phase II clinical trial in relapsed or refractory hodgkin lymphoma; and in Phase Ib clinical trial for selected advanced solid tumors. In addition, it develops ADCT-602, which is in Phase Ia clinical trial for treatment of acute lymphoblastic leukemia; ADCT-601 and ADCT-901 that are in Phase Ia clinical trial for treatment of various solid tumors; and preclinical product candidates, including ADCT-701 and ADCT-901 for the treatment of solid tumors. It has a collaboration and license agreement with Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.